Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Update
by Jessica Moore · The Cerbat GemAstrana Health, Inc. (NASDAQ:ASTH – Get Free Report) saw a large growth in short interest in December. As of December 15th, there was short interest totaling 2,982,920 shares, a growth of 25.3% from the November 30th total of 2,380,737 shares. Approximately 5.8% of the company’s stock are short sold. Based on an average daily volume of 494,597 shares, the days-to-cover ratio is currently 6.0 days. Based on an average daily volume of 494,597 shares, the days-to-cover ratio is currently 6.0 days. Approximately 5.8% of the company’s stock are short sold.
Institutional Investors Weigh In On Astrana Health
A number of institutional investors have recently added to or reduced their stakes in ASTH. Hsbc Holdings PLC bought a new position in shares of Astrana Health during the 1st quarter worth approximately $200,000. Royal Bank of Canada increased its position in shares of Astrana Health by 6.5% during the first quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after acquiring an additional 17,028 shares during the last quarter. AQR Capital Management LLC bought a new stake in Astrana Health during the first quarter worth $933,000. Jacobs Levy Equity Management Inc. lifted its holdings in Astrana Health by 211.6% during the first quarter. Jacobs Levy Equity Management Inc. now owns 237,926 shares of the company’s stock worth $7,378,000 after acquiring an additional 161,580 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Astrana Health by 5.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after purchasing an additional 1,263 shares during the last quarter. 52.77% of the stock is owned by institutional investors.
Astrana Health Trading Down 0.6%
Shares of Astrana Health stock opened at $24.81 on Thursday. The stock has a fifty day simple moving average of $25.22 and a 200 day simple moving average of $26.66. Astrana Health has a 12-month low of $20.12 and a 12-month high of $39.97. The company has a market capitalization of $1.40 billion, a P/E ratio of 130.59, a price-to-earnings-growth ratio of 1.51 and a beta of 0.86. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27.
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings data on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The business had revenue of $317.00 million for the quarter. On average, sell-side analysts anticipate that Astrana Health will post 1.15 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on ASTH shares. Zacks Research downgraded Astrana Health from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Weiss Ratings restated a “sell (d+)” rating on shares of Astrana Health in a report on Monday. Jefferies Financial Group reaffirmed a “buy” rating on shares of Astrana Health in a research report on Tuesday, November 25th. Barclays reduced their price target on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research report on Monday, November 24th. Finally, BTIG Research decreased their price target on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a research note on Friday, November 7th. Eight investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $41.33.
View Our Latest Stock Report on Astrana Health
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.